Correlation Between Indaptus Therapeutics and Erasca
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Erasca Inc, you can compare the effects of market volatilities on Indaptus Therapeutics and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Erasca.
Diversification Opportunities for Indaptus Therapeutics and Erasca
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Indaptus and Erasca is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Erasca go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Erasca
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 1.24 times more return on investment than Erasca. However, Indaptus Therapeutics is 1.24 times more volatile than Erasca Inc. It trades about 0.0 of its potential returns per unit of risk. Erasca Inc is currently generating about -0.01 per unit of risk. If you would invest 181.00 in Indaptus Therapeutics on December 12, 2024 and sell it today you would lose (97.00) from holding Indaptus Therapeutics or give up 53.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Indaptus Therapeutics vs. Erasca Inc
Performance |
| Timeline |
| Indaptus Therapeutics |
| Erasca Inc |
Indaptus Therapeutics and Erasca Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and Erasca
The main advantage of trading using opposite Indaptus Therapeutics and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.| Indaptus Therapeutics vs. Rezolute | ||
| Indaptus Therapeutics vs. Tempest Therapeutics | ||
| Indaptus Therapeutics vs. Forte Biosciences | ||
| Indaptus Therapeutics vs. ABVC Biopharma |
| Erasca vs. Century Therapeutics | ||
| Erasca vs. Keros Therapeutics | ||
| Erasca vs. Monte Rosa Therapeutics | ||
| Erasca vs. Design Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |